Search for: "Shire US, Inc." Results 1 - 20 of 101
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Jan 2023, 6:13 am by Unknown
As for Ryne Miller, he said Miller is employed by Debtor West Realm Shires, Inc., “but has no day-to-day responsibilities. [read post]
1 Jun 2021, 12:14 pm by Rohini Kurup
If you have an announcement to add to the page, email us. [read post]
12 Mar 2020, 6:49 am by Rebecca Tushnet
As the court pointed out, unlike with a drug or device, the consumer could read the book and decide not to use the advice, and the book would still have succeeded in its intended function: being read.Thus, when the ads for the book just describe the contents of the book, they’re protected to the same level as the book itself. [read post]
17 Jun 2019, 7:36 am by Dan Bressler
” “In his motion, Darken said Vinca’s current counsel have improperly used confidential emails from Barry A. [read post]
29 Mar 2018, 7:05 am by Leonard Gordon and Mary Gardner
The FTC brought the action against Shire for allegedly using the FDA’s citizen petition process to delay the FDA’s approval of a generic version of its drug, Vancocin, in violation of Section 5(a) of the FTC Act. [read post]
26 Dec 2017, 7:08 pm by Ben Vernia
  Shire Pharmaceuticals LLC paid $350 million to resolve allegations that Shire and the company it acquired in 2011, Advanced BioHealing (ABH), induced clinics and physicians to use or overuse its bioengineered human skin substitute by offering lavish dinners, drinks, entertainment and travel; medical equipment and supplies; unwarranted payments for purported speaking engagements and bogus case studies; and cash, credits and rebates. [read post]
1 Dec 2017, 11:35 am by Nate Nead
Paganini will complement OncoResponse, since OncoResponse has a strong focus on antibody cancer drugs and Paganini recently developed ONCR-201, a monoclonal antibody used in treating ovarian cancer.[29] Mallinckrodt PLC is expected to purchase Ocera Therapeutics Inc. in addition to its mid-stage hepatic encephalopathy, for about $42 million and to close in the fourth quarter of 2017. [read post]